Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Julian
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   33    
Direct Shares   1,028,565    

Indirect Shares

   243,774,473      
Direct Value   $74,412,006    

Indirect Value

   $16,676,232,797      
Total Shares   244,803,038      
Total Value   $16,750,644,803      


Incyte Corp $32,589,847 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,254,997 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,499,117 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $285,967 Incyte Corp $32,589,847 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,254,997 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,499,117 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $285,967
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    46   
    7    

     Stock price went up :
    23   
    7    
     Stock price went down :
    23   
    0    
   
     Gain/Loss Ratio :
   0.0   
   7.0   
     Percentage Gain/Loss :
   11.8%
 80.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA 10% Owner 2003-09-26 0 2011-11-02 144,082    Premium*  
            Innoviva Inc INVA Director 2005-12-13 0 2004-10-04 33,839    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2004-10-13 0 2011-06-30 4,045,398    Premium*  
            Incyte Corp INCY 2024-05-07 559,963 2024-05-07 33,496,391    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2019-08-29 0 2019-08-29 9,262,659    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 2009-01-23 0 2009-01-23 2,258    Premium*  
            Viropharma Inc VPHM 10% Owner 0 2011-12-14 9,840,469    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2009-10-19 5,264,782    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2012-01-27 0    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 2011-08-22 0 2012-02-10 557,211    Premium*  
            XOMA Corporation XOMA Former 10% owner 0 2015-07-22 90,538    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 3,540,015    Premium*  
            Neurogene NGNE Director 2020-07-07 4,520 2020-07-07 3,501,691    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2021-06-22 205,752 2021-06-22 38,452,877    Premium*  
            Invitae Corp NVTA 10% Owner 2018-03-28 0 2018-03-28 7,553,553    Premium*  
            Aceragen, Inc ACGN 10% Owner 2019-07-01 43,858 2019-07-01 4,290,995    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM Former 10% owner 2017-10-05 0 2017-10-05 1,878,242    Premium*  
            Mirati Therapeutics, Inc. MRTX 10% Owner 2017-11-08 274 2017-11-08 35,999    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 2018-01-17 0 2018-01-19 58,131    Premium*  
            Beigene Ltd BGNE Director, 10% Owner 2021-06-16 20,838 2021-06-16 11,703,086    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2021-05-14 46,557 2021-05-14 43,309,073    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2020-05-14 131,963 2020-05-14 7,940,623    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA Director, 10% Owner 2019-06-06 14,840 2019-06-06 2,700,597    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2018-10-09 0 2021-09-30 13,526,726    Premium*  
            Atreca Inc BCEL 10% Owner 2019-06-24 0 2019-06-24 3,223,030    Premium*  
            Igm Biosciences, Inc. IGMS Director, 10% Owner 2019-09-20 0 2021-01-27 2,895,306    Premium*  
            Prelude Therapeutics Inc PRLD Director, 10% Owner 0 2021-01-27 9,252,951    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 0 2021-01-01 4,286,038    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 0 2021-02-17 7,003,766    Premium*  
            Aeglea Biotherapeutics, Inc. AGLE Director 0 2021-02-23 3,410,106    Premium*  
            Tscan Therapeutics, Inc. TCRX Director 2021-07-20 0 2021-07-20 1,320,302    Premium*  
            Entrada Therapeutics, Inc. TRDA 10% Owner 0 2021-12-14 4,704,419    Premium*  
            Bicycle Therapeutics Ltd BCYC 0 2024-04-18 6,449,320    Premium*  
* Premium Members only  

Records found :    496         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 19 of 20
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
VPHM Viropharma Inc 10% Owner   –       –       •   2011-10-03 4 B $17.62 $9,134,858 I/I 516,203 9,357,416 1.5 -
RDEA Ardea Biosciences Inc Director   –       •       •   2011-01-20 4 B $26.00 $9,245,210 I/I 355,585 4,036,097 2.25 -
ACGN Aceragen, Inc Director   –       •       •   2018-03-15 4 OE $0.47 $9,548,674 I/I 20,316,327 602,867 0 -
RDEA Ardea Biosciences Inc Director   –       •       •   2010-04-06 4 B $20.00 $9,731,380 I/I 486,569 3,680,512 2.25 -
XOMA XOMA Corporation Director   –       •       •   2013-08-19 4/A B $3.62 $9,983,203 I/I 2,757,791 510,449 2.25 -
XOMA XOMA Corporation Director   –       •       •   2013-08-19 4 A $3.62 $9,983,203 I/I 2,757,791 510,449 0 -
RDEA Ardea Biosciences Inc 10% Owner   –       –       •   2007-12-19 4 B $13.25 $9,997,377 I/I 754,519 1,930,363 1.5 -
SGEN Seagen Inc Director   –       •       •   2018-05-04 4 B $52.68 $10,775,582 I/I 204,537 45,569,872 2.25 -
VPHM Viropharma Inc 10% Owner   –       –       •   2010-04-29 4 B $12.98 $11,904,544 I/I 914,504 8,649,510 1.5 -
KOD Kodiak Sciences Inc. Director   –       •       •   2020-02-25 4 B $57.22 $11,937,248 I/I 206,126 10,373,248 2.25 %
ACGN Aceragen, Inc Director   –       •      –    2017-10-26 4 B $1.50 $12,000,000 I/I 8,000,000 16,557,473 2.1 -
XOMA XOMA Corporation Former 10% owner   –       –      –    2015-07-22 4 S $1.09 $12,017,500 I/I (11,000,000) 90,538 0 -
INCY Incyte Corp Director   –       •       •   2021-12-16 4 B $71.96 $12,184,411 I/I 169,315 29,856,824 2.25 %
INCY Incyte Corp Director   –       •       •   2009-09-24 4 A $6.75 $12,475,350 I/I 1,848,200 8,929,705 0 -
KOD Kodiak Sciences Inc. Director   –       •       •   2021-06-30 4 B $89.74 $14,350,692 I/I 155,577 12,994,485 2.25 %
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2019-05-29 4 S $121.37 $14,548,851 I/I (119,062) 7,434,266 0 -
RYTM Rhythm Pharmaceuticals, I... Former 10% owner   –       –      –    2017-10-05 4 B $17.00 $15,045,000 I/I 885,000 1,878,242 0.01 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2019-05-28 4 S $125.05 $15,624,859 I/I (123,489) 7,540,560 0 -
SGEN Seagen Inc Director   –       •       •   2018-05-01 4 B $51.14 $15,764,736 I/I 306,917 45,295,388 2.25 -
ALXN Alexion Pharmaceuticals I... Director   –       •      –    2020-03-16 4 B $75.66 $20,894,753 I/I 265,298 7,626,298 2.1 %
TCRX Tscan Therapeutics, Inc. Director   –       •      –    2021-07-20 4 B $15.00 $21,375,000 I/I 1,425,000 1,320,302 2.1 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2020-03-16 4 B $31.19 $21,878,017 I/I 694,303 38,107,749 2.25 %
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2018-09-20 4 B $18.64 $22,646,989 I/I 1,210,776 24,798,117 2.25 -
KOD Kodiak Sciences Inc. Director   –       •       •   2018-10-09 4 B $10.00 $25,000,000 I/I 2,500,000 8,374,935 2.25 -
INCY Incyte Corp Director   –       •       •   2021-12-15 4 B $67.90 $25,052,340 I/I 350,332 29,687,509 2.25 %
  496  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19  20      
  Page 19 of 20  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us